In a 2005 study by Anisimov et al., lifelong metformin administration (240 mg/kg body weight) starting at two months of age in transgenic FVB/N female mice with the HER-2/neu mammary cancer gene led to an approximate 8% increase in lifespan [73]. This evidence concerns the gene ERBB2 and breast cancer.